Clinical features of microdeletion 9q22.3 (pat)

Clinical Genetics

Volumn 75, Issue 4, 2009, Pages 384-393

  Shimojima, K ^a   Adachi, M ^b   Tanaka, M ^b   Tanaka, Y ^b   Kurosawa, K ^b   Yamamoto, Toshiyuki ^a,b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

9q22.3; Genomic imprinting; Gorlin syndrome; Microarray based comparative genomic hybrdization; Overgrowth; PTCH1

Indexed keywords

PROTEIN PATCHED 1;

ADOLESCENT; ADULT; ARTICLE; BASAL CELL NEVUS SYNDROME; CEREBELLUM DISEASE; CHILD; CHROMOSOME 9Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DYSPLASIA; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE LOSS; GENETIC SCREENING; GROWTH DISORDER; HEMANGIOMA; HUMAN; INFANT; MALE; MENINX DISORDER; PRIORITY JOURNAL;

BASAL CELL NEVUS SYNDROME; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; DEVELOPMENTAL DISABILITIES; FATHERS; FEMALE; GENOMIC IMPRINTING; HUMANS; INFANT, NEWBORN; RECEPTORS, CELL SURFACE;

EID: 65249162141     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01141.x     Document Type: Article

References (34)

1. Faivre L, Gosset P, Cormier-Daire V et al. Overgrowth and trisomy 15q26.1-qter including the IGF1 receptor gene: Report of two families and review of the literature. Eur J Hum Genet 2002: 10: 699-706.
2. Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet 2007: 15: 264-271.
3. Cooper WN, Luharia A, Evans GA et al. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2005: 13: 1025-1032.
4. Sakazume S, Okamoto N, Yamamoto T et al. GPC3 mutations in seven patients with Simpson-Golabi-Behmel syndrome. Am J Med Genet A 2007: 143: 1703-1707.
5. Smith AC, Choufani S, Ferreira JC, Weksberg R. Growth regulation, imprinted genes, and chromosome 11p15.5. Pediatr Res 2007: 61: 43R-47R.
6. Douglas J, Cilliers D, Coleman K et al. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet 2007: 39: 963-965.
7. Redon R, Baujat G, Sanlaville D et al. Interstitial 9q22.3 microdeletion: Clinical and molecular characterisation of a newly recognised overgrowth syndrome. Eur J Hum Genet 2006: 14: 759-767.
8. Kono Y, Mishina J, Sato N, Watanabe T, Honma Y. Developmental characteristics of very low-birthweight infants at 18 months'corrected age according to birthweight. Pediatr Int 2008: 50: 23-28.
9. Toruner GA, Streck DL, Schwalb MN, Dermody JJ. An oligonucleotide based array-CGH system for detection of genome wide copy number changes including subtelomeric regions for genetic evaluation of mental retardation. Am J Med Genet A 2007: 143: 824-829.
10. Shimokawa O, Kurosawa K, Ida T et al. Molecular characterization of inv dup del(8p): Analysis of five cases. Am J Med Genet A 2004: 128: 133-137.
11. Nelen MR, Kremer H, Konings IB et al. Novel PTEN mutations in patients with Cowden disease: Absence of clear genotype-phenotype correlations. Eur J Hum Genet 1999: 7: 267-273.
12. Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996: 272: 1668-1671.
13. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004: 6: 530-539.
14. Kimonis VE, Mehta SG, Digiovanna JJ, Bale SJ, Pastakia B. Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet Med 2004: 6: 495-502.
15. Turleau C, de Grouchy J, Chabrolle JP. Intercalary deletions of 9q. Ann Genet 1978: 21: 234-236.
16. Sekhon G, Hermann J, Neu J, Sun J. Interstitial deletion of the 9q22q32 region causes a distinct syndrome. 1982: Unpublished abstract.
17. Ying KL, Curry CJ, Rajani KB, Kassel SH, Sparkes RS. De novo interstitial deletion in the long arm of chromosome 9: A new chromosome syndrome. J Med Genet 1982: 19: 68-70.
18. Farrell SA, Siegel-Bartelt J, Teshima I. Patients with deletions of 9q22q34 do not define a syndrome: Three case reports and a literature review. Clin Genet 1991: 40: 207-214.
19. Robb L, Vekemans M, Richter A, Meagher-Villemure K, Neilen K, der Kaloustian V. Interstitial deletion of the long arm of chromosome 9. Am J Hum Genet 1991: 49 (Suppl. 274).
20. Kroes HY, Tuerlings JH, Hordijk R, Folkers NR, ten Kate LP. Another patient with an interstitial deletion of chromosome 9: Case report and a review of six cases with del(9)(q22q32). J Med Genet 1994: 31: 156-158.
21. Shimkets R, Gailani MR, Siu VM et al. Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients. Am J Hum Genet 1996: 59: 417-422.
22. Sasaki K, Yoshimoto T, Nakao T et al. [A nevoid basal cell carcinoma syndrome with chromosomal aberration]. No To Hattatsu 2000: 32: 49-55.
23. Fujii K, Ishikawa S, Uchikawa H et al. High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome. Hum Genet 2007: 122: 459-466.
24. Paoloni-Giacobino A, Floris E, Dahoun SP. Fetus with a 9q22q34 interstitial deletion and hygroma. Prenat Diagn 2000: 20: 855-856.
25. Olivieri C, Maraschio P, Caselli D et al. Interstitial deletion of chromosome 9, int del(9)(9q22.31-q31.2), including the genes causing multiple basal cell nevus syndrome and Robinow/brachydactyly 1 syndrome. Eur J Pediatr 2003: 162: 100-103.
26. Haniffa MA, Leech SN, Lynch SA, Simpson NB. NBCCS secondary to an interstitial chromosome 9q deletion. Clin Exp Dermatol 2004: 29: 542-544.
27. Midro AT, Panasiuk B, Tumer Z et al. Interstitial deletion 9q22.32-q33.2 associated with additional familial translocation t(9;17)(q34.11;p11.2) in a patient with Gorlin-Goltz syndrome and features of Nail-Patella syndrome. Am J Med Genet A 2004: 124: 179-191.
28. Boonen SE, Stahl D, Kreiborg S et al. Delineation of an interstitial 9q22 deletion in basal cell nevus syndrome. Am J Med Genet A 2005: 132: 324-328.
29. Cajaiba MM, Bale AE, Alvarez-Franco M, McNamara J, Reyes-Mugica M. Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome. Nat Clin Pract Oncol 2006: 3: 575-580.
30. Chen CP, Lin SP, Wang TH, Chen YJ, Chen M, Wang W. Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3->q31.3) associated with Gorlin syndrome. Prenat Diagn 2006: 26: 725-729.
31. Nowakowska B, Kutkowska-Kazmierczak A, Stankiewicz P et al. A girl with deletion 9q22.1-q22.32 including the PTCH and ROR2 genes identified by genome-wide array-CGH. Am J Med Genet A 2007: 143: 1885-1889.
32. Patel S, Barkovich AJ. Analysis and classification of cerebellar malformations. AJNR Am J Neuroradiol 2002: 23: 1074-1087.
33. Hahn H, Wicking C, Zaphiropoulous PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996: 85: 841-851.
34. Hahn H, Wojnowski L, Specht K et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J Biol Chem 2000: 275: 28341-28344.